DK1026167T3 - Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler - Google Patents

Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

Info

Publication number
DK1026167T3
DK1026167T3 DK98944289T DK98944289T DK1026167T3 DK 1026167 T3 DK1026167 T3 DK 1026167T3 DK 98944289 T DK98944289 T DK 98944289T DK 98944289 T DK98944289 T DK 98944289T DK 1026167 T3 DK1026167 T3 DK 1026167T3
Authority
DK
Denmark
Prior art keywords
antiallergic agents
preparation
alkyl
chem
alkoxy
Prior art date
Application number
DK98944289T
Other languages
English (en)
Inventor
Yasuo Ohtsuka
Toshio Nishizuka
Sohjiro Shiokawa
Seiji Tsutsumi
Mami Kawaguchi
Hideo Kitagawa
Hiromi Takata
T Shishikura
T Ishikura
Kenichi Fushihara
Yumiko Okada
Sachiko Miyamoto
Maki Shiobara
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of DK1026167T3 publication Critical patent/DK1026167T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98944289T 1997-09-29 1998-09-29 Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler DK1026167T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04
PCT/JP1998/004363 WO1999016770A1 (en) 1997-09-29 1998-09-29 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic

Publications (1)

Publication Number Publication Date
DK1026167T3 true DK1026167T3 (da) 2003-05-26

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944289T DK1026167T3 (da) 1997-09-29 1998-09-29 Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

Country Status (24)

Country Link
US (3) US6372735B1 (da)
EP (1) EP1026167B1 (da)
JP (1) JP3188482B2 (da)
KR (1) KR100389140B1 (da)
CN (2) CN1155599C (da)
AT (1) ATE233764T1 (da)
AU (1) AU744636B2 (da)
BR (1) BR9814055B1 (da)
CA (1) CA2305307C (da)
DE (1) DE69811930T2 (da)
DK (1) DK1026167T3 (da)
ES (1) ES2191963T3 (da)
HU (1) HUP0004020A3 (da)
ID (1) ID24101A (da)
IL (1) IL135303A0 (da)
NO (2) NO319542B1 (da)
NZ (1) NZ503601A (da)
PL (1) PL339544A1 (da)
PT (1) PT1026167E (da)
RU (1) RU2198885C2 (da)
SK (1) SK283869B6 (da)
TR (1) TR200000808T2 (da)
TW (1) TW510902B (da)
WO (1) WO1999016770A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7002009B2 (en) * 2001-12-26 2006-02-21 Meiji Seika Kaisha, Ltd. Crystalline tricyclic triazolobenzazepine derivative
ATE359277T1 (de) * 2002-02-01 2007-05-15 Meiji Seika Kaisha Verfahren zur herstellung einer 1,2,3- triazolverbindung
WO2004004665A2 (en) 2002-07-09 2004-01-15 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JP4541883B2 (ja) 2002-07-09 2010-09-08 ブリストル−マイヤーズ スクイブ カンパニー 抗糖尿病薬および抗肥満症薬として有用な置換へテロ環誘導体、並びに方法
US20070167432A1 (en) * 2003-06-19 2007-07-19 Meiji Seila Kaisha, Ltd Tricyclic triazolobenzapine derivative produced as novel crystalline substance
US20070167402A1 (en) * 2003-06-20 2007-07-19 Meiji Seika Kaisha, Ltd. Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same
HRP20080120T5 (hr) 2004-05-14 2012-07-31 Millennium@Pharmaceuticals Spojevi i postupci za inhibiciju napredovanja mitoze s pomoću inhibicije aurora kinaze
BRPI0708448A2 (pt) * 2006-03-02 2011-06-07 Meiji Seika Kaisha composição farmacêutica, método para a profilaxia ou tratamento de doenças oftálmicas alérgicas ou doenças nasais alérgicas, e, uso de um composto
EP2094711B8 (de) * 2006-09-25 2018-03-28 Forschungsverbund Berlin e.V. Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
KR101216756B1 (ko) 2007-12-18 2012-12-28 메이지 세이카 파루마 가부시키가이샤 염증성 장질환의 예방 또는 치료제
WO2010074724A1 (en) 2008-12-22 2010-07-01 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd20 antibodies
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011084848A2 (en) 2010-01-07 2011-07-14 Alkermes, Inc. Prodrugs of heteraromatic compounds
RU2012140021A (ru) 2010-02-19 2014-03-27 Миллениум Фармасьютикалз, Инк. КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНИЛ)-5Н-ПИРИМИДО[5,4-d][2]БЕНЗАЗЕПИН-2-ИЛ]АМИНО}-2-МЕТОКСИБЕНЗОАТА НАТРИЯ
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (en) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
KR20200112860A (ko) * 2017-12-29 2020-10-05 바이오마린 파머수티컬 인크. 질환의 치료를 위한 글리콜레이트 산화효소 억제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024087A1 (fr) 1993-04-16 1994-10-27 Shionogi & Co., Ltd. Procede pour produire un compose de lignane
DE69427023T2 (de) 1993-12-28 2001-10-31 Meiji Seika K.K., Tokio/Tokyo Tricyclische benzazepin-und benzothiazepin derivate
WO1997000258A1 (en) * 1995-06-15 1997-01-03 Meiji Seika Kabushiki Kaisha Tricyclic benzazepine compounds
TW486480B (en) * 1996-03-08 2002-05-11 Zeneca Ltd Azolobenzazepine derivatives and compositions and method of use thereof
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
WO1999016770A1 (en) 1999-04-08
ES2191963T3 (es) 2003-09-16
US7022860B2 (en) 2006-04-04
CN1155599C (zh) 2004-06-30
US7238812B2 (en) 2007-07-03
CN1523019A (zh) 2004-08-25
NO20001500L (no) 2000-05-18
ATE233764T1 (de) 2003-03-15
BR9814055B1 (pt) 2009-05-05
EP1026167B1 (en) 2003-03-05
DE69811930T2 (de) 2003-12-18
HUP0004020A3 (en) 2002-12-28
BR9814055A (pt) 2000-09-26
CA2305307A1 (en) 1999-04-08
SK283869B6 (sk) 2004-03-02
US6372735B1 (en) 2002-04-16
JP3188482B2 (ja) 2001-07-16
NZ503601A (en) 2002-02-01
AU9186998A (en) 1999-04-23
IL135303A0 (en) 2001-05-20
TW510902B (en) 2002-11-21
CN1278262A (zh) 2000-12-27
PT1026167E (pt) 2003-07-31
EP1026167A4 (en) 2001-07-11
RU2198885C2 (ru) 2003-02-20
NO319542B1 (no) 2005-08-29
NO20001500D0 (no) 2000-03-23
EP1026167A1 (en) 2000-08-09
AU744636B2 (en) 2002-02-28
TR200000808T2 (tr) 2000-08-21
NO20043765L (no) 2000-05-18
KR100389140B1 (ko) 2003-06-25
HK1032782A1 (en) 2002-08-30
CN1312135C (zh) 2007-04-25
SK4252000A3 (en) 2000-10-09
ID24101A (id) 2000-07-06
KR20010030784A (ko) 2001-04-16
US20020137739A1 (en) 2002-09-26
HUP0004020A2 (hu) 2001-09-28
PL339544A1 (en) 2000-12-18
CA2305307C (en) 2004-11-30
DE69811930D1 (de) 2003-04-10
US20060074074A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
DK1026167T3 (da) Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
IL113313A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
DK0868182T3 (da) Fremgangsmåde til fremstilling af piperidinderivater
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
EP1094055A4 (en) NEW VINYLBENZENE DERIVATIVES
NO940831L (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
DK0664287T3 (da) Vitamin D-forbindelser og fremgangsmåde til fremstilling af disse
BG102488A (en) Pesticidal compounds, compositions and methods for their preparation
NO20003604L (no) Nye tricykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
AU7332996A (en) Therapeutics for thrombocytopenia
AR017971A1 (es) DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS.
AU2639999A (en) Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives
EP0502488A3 (en) Phosphorus-containing azetidin-2-one derivatives
EP1251129A4 (en) PYRIMIDINE DERIVATIVES WITH ANTI-TUMOR EFFECT
TW430666B (en) New 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
MX9704976A (es) Derivados de 1,2,3-benzotiadiazol.
EP1362853A4 (en) STYRENE DERIVATIVES AND MANUFACTURING METHOD THEREOF